A polymorphism in the protease-like domain of Apolipoprotein(A) associated with severe coronary artery disease

被引：0
|
作者：
Luke, May M.
Kane, John P.
Liu, Dongming M.
Rowland, Charles M.
Shiffman, Dov
Cassano, June
Catanese, Joseph J.
Pullinger, Clive R.
Leong, Diane U.
Arellano, Andre R.
Tong, Carmen H.
Movsesyan, Irina
Naya-Vigne, Joselphina
Noordhof, Curtis
Feric, Nicole T.
Malloy, Mary J.
Topol, Eric J.
Koschinsky, Marlys L.
Devlin, James J.
Ellis, Stephen G.
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[3] Queens Univ, Kingston, ON K7L 3N6, Canada
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2007年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E116 / E116
页数：1
相关论文
共 50 条
  • [21] A Prospective Correlation of Apolipoprotein M Gene Polymorphism with Premature Coronary Artery Disease
    Li, Bao
    CIRCULATION, 2010, 122 (02) : E372 - E372
  • [22] The role of the apolipoprotein E polymorphism in the prediction of coronary artery disease age of onset
    Moore, JH
    Reilly, SL
    Ferrell, RE
    Sing, CF
    CLINICAL GENETICS, 1997, 51 (01) : 22 - 25
  • [23] Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia
    Emanuele, E
    Peros, E
    Minoretti, P
    D'Angelo, A
    Piccinni, MN
    Montagna, L
    Geroldi, D
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2004, 14 (04) : 193 - 199
  • [24] HPA1 POLYMORPHISM IN APOLIPOPROTEIN C1 GENE IS ASSOCIATED WITH CORONARY ARTERY DISEASE SEVERITY
    Pillois, X.
    Do Thi, N. P.
    Reynaud, A.
    Benchimol, D.
    Bonnet, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [25] Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease
    Petrovic, D
    Zorc, M
    Peterlin, B
    FOLIA BIOLOGICA, 2000, 46 (05) : 181 - 185
  • [26] Matrix metalloproteinase 13 genotype in rs640198 polymorphism is associated with severe coronary artery disease
    Vasku, Anna
    Meluzin, Jaroslav
    Blahak, Jan
    Kincl, Vladimir
    Goldbergova, Monika Pavkova
    Sitar, Jan
    Zlamal, Filip
    Bienertova-Vasku, Julie
    Vitovec, Jiri
    DISEASE MARKERS, 2012, 33 (01) : 43 - 49
  • [27] Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS)
    Maitland-van der Zee, AH
    Jukema, JW
    Zwinderman, AH
    Hallman, DM
    de Boer, A
    Kastelein, JJP
    de Knijff, P
    ACTA CARDIOLOGICA, 2006, 61 (03) : 327 - 331
  • [28] Apolipoprotein E polymorphism, paraoxonase-1 activity and coronary artery disease: Is there a link
    Nabatchian, F.
    Khaghani, Sh.
    Miri, R.
    Mahmoodi, M.
    Karimi, A.
    Pasalar, R.
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2008, 24 (02) : 204 - 208
  • [29] Apolipoprotein E polymorphism is associated with both number of diseased vessels and extent of coronary artery disease in Czech patients with CAD
    Machal, Jan
    Vasku, Anna
    Hlinomaz, Ota
    Linhartova, Petra
    Groch, Ladislav
    Vitovec, Jiri
    BIOMEDICAL PAPERS-OLOMOUC, 2012, 156 (02): : 151 - 158
  • [30] Association of apolipoprotein E polymorphism with myocardial infarction in Greek patients with coronary artery disease
    Kolovou, G
    Yiannakouris, N
    Hatzivassiliou, M
    Malakos, J
    Daskalova, D
    Hatzigeorgiou, G
    Cariolou, MA
    Cokkinos, DV
    CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (03) : 118 - 124
12345